A snapshot of the ATAC-seq profiles showed that there were more accessible peaks at known MLL-r target genes (HOXA3, HOXA9 and HOXA10) in MLL-r AML cells compared to CD34+ control cells (Fig. 1C). The gene discussed is HOXA10; the disease is acute myeloid leukemia.